These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 16555126)
1. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Kumar R; Chauhan A; Zhuang H; Chandra P; Schnall M; Alavi A Breast Cancer Res Treat; 2006 Aug; 98(3):267-74. PubMed ID: 16555126 [TBL] [Abstract][Full Text] [Related]
3. FDG PET, PET/CT, and breast cancer imaging. Rosen EL; Eubank WB; Mankoff DA Radiographics; 2007 Oct; 27 Suppl 1():S215-29. PubMed ID: 18180228 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging. Caresia Aroztegui AP; García Vicente AM; Alvarez Ruiz S; Delgado Bolton RC; Orcajo Rincon J; Garcia Garzon JR; de Arcocha Torres M; Garcia-Velloso MJ; Tumour Biol; 2017 Oct; 39(10):1010428317728285. PubMed ID: 29025377 [TBL] [Abstract][Full Text] [Related]
5. Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer. Robson N; Thekkinkattil DK Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399608 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Approach and Differences between Spinal Infections and Tumors. Compagnone D; Cecchinato R; Pezzi A; Langella F; Damilano M; Redaelli A; Vanni D; Lamartina C; Berjano P; Boriani S Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685273 [TBL] [Abstract][Full Text] [Related]
7. Advances in PET/CT Imaging for Breast Cancer. de Jong D; Desperito E; Al Feghali KA; Dercle L; Seban RD; Das JP; Ma H; Sajan A; Braumuller B; Prendergast C; Liou C; Deng A; Roa T; Yeh R; Girard A; Salvatore MM; Capaccione KM J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445572 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of Dedicated Breast Positron Emission Tomography Image Denoising Using a Residual Neural Network. Itagaki K; Miyake KK; Tanoue M; Oishi T; Kataoka M; Kawashima M; Toi M; Nakamoto Y Asia Ocean J Nucl Med Biol; 2023; 11(2):145-157. PubMed ID: 37324225 [TBL] [Abstract][Full Text] [Related]
9. Deep Learning-Based Image Quality Improvement in Digital Positron Emission Tomography for Breast Cancer. Mori M; Fujioka T; Hara M; Katsuta L; Yashima Y; Yamaga E; Yamagiwa K; Tsuchiya J; Hayashi K; Kumaki Y; Oda G; Nakagawa T; Onishi I; Kubota K; Tateishi U Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832283 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of dedicated breast positron emission tomography. Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684 [TBL] [Abstract][Full Text] [Related]
12. Clinical advances in PET-MRI for breast cancer. Fowler AM; Strigel RM Lancet Oncol; 2022 Jan; 23(1):e32-e43. PubMed ID: 34973230 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of [ Iqbal R; Mammatas LH; Aras T; Vogel WV; van de Brug T; Oprea-Lager DE; Verheul HMW; Hoekstra OS; Boellaard R; Menke-van der Houven van Oordt CW Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829301 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Histopathological Features of Early-stage Invasive Ductal Breast Carcinoma by Erol M; Önner H; Eren Karanis Mİ Mol Imaging Radionucl Ther; 2021 Oct; 30(3):129-136. PubMed ID: 34658227 [TBL] [Abstract][Full Text] [Related]
15. A Prospective Study Comparing the Role of 18 FDG PET-CT with Contrast-Enhanced Computed Tomography and Tc99m Bone Scan for Staging Locally Advanced Breast Cancer. Bhoriwal S; Deo SVS; Kumar R; Thulkar S; Gogia A; Sharma DN; Mathur S Indian J Surg Oncol; 2021 Jun; 12(2):266-271. PubMed ID: 34295069 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of image quality at the detector's edge of dedicated breast positron emission tomography. Satoh Y; Motosugi U; Imai M; Omiya Y; Onishi H EJNMMI Phys; 2021 Jan; 8(1):5. PubMed ID: 33462645 [TBL] [Abstract][Full Text] [Related]
17. Role of Abouzied MM; Fathala A; AlMuhaideb A; Al Qahtani MH World J Nucl Med; 2020; 19(3):187-196. PubMed ID: 33354172 [TBL] [Abstract][Full Text] [Related]
18. Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography. Satoh Y; Sekine T; Omiya Y; Onishi H; Motosugi U EJNMMI Phys; 2019 Nov; 6(1):21. PubMed ID: 31784863 [TBL] [Abstract][Full Text] [Related]
19. Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. Meyer HJ; Wienke A; Surov A PLoS One; 2019; 14(6):e0217781. PubMed ID: 31206524 [TBL] [Abstract][Full Text] [Related]
20. A preliminary study to propose a diagnostic algorithm for PET/CT-detected incidental breast lesions: application of BI-RADS lexicon for US in combination with SUVmax. Bakhshayeshkaram M; Salehi Y; Abbasi M; Hashemi Beni R; Seifi S; Hassanzad M; Jamaati HR; Aghahosseini F Eur Radiol; 2019 Oct; 29(10):5507-5516. PubMed ID: 30887201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]